Lipocine Inc. (LPCN) Financials

LPCN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 23.8 million 2.1 million
March 31, 2026 25.4 million 2.5 million
Dec. 31, 2025 17.0 million 2.5 million
Sept. 30, 2025 16.1 million 1.9 million

LPCN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.0 million 58145
March 31, 2026 -2.3 million 65398
Dec. 31, 2025 -2.9 million 53032
Sept. 30, 2025 -3.0 million 53256

LPCN Net Income

No data available :(

LPCN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 23.3 million - -
March 31, 2026 24.7 million - -
Dec. 31, 2025 14.9 million - 449591
Sept. 30, 2025 15.1 million - 157200

LPCN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 8.2 million
March 31, 2026 6.8 million
Dec. 31, 2025 5.7 million
Sept. 30, 2025 5.4 million

LPCN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 2.0 million 990956 -
March 31, 2026 3 2.7 million 1.2 million -
Dec. 31, 2025 3 2.7 million 983390 -
Sept. 30, 2025 3 2.7 million 767837 -

LPCN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 190099 2.0 million
March 31, 2026 119397 14814
Dec. 31, 2025 1.1 million 14981
Sept. 30, 2025 114574 -

LPCN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LPCN

Price: $2.04

52 week price:
1.81
12.37

Earnings Per Share: -1.85 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 27881

Ebitda: -4.8 million

Market Capitalization: 17.6 million

Links: